Today: 16 July 2026
CrowdStrike (CRWD) stock rises as JPMorgan flags ‘AI-disruption’ selloff as overdone
10 February 2026
2 mins read

CrowdStrike (CRWD) stock rises as JPMorgan flags ‘AI-disruption’ selloff as overdone

New York, February 10, 2026, 15:07 (ET) — Regular session

  • CrowdStrike climbed roughly 2.2% in afternoon action, stretching a comeback rally among battered software stocks.
  • JPMorgan and Morgan Stanley flagged a drop in software valuations, blaming sentiment—fresh worries about AI disruption are rattling the sector.
  • Next up: investors are zeroing in on March 3 results, looking for signals on demand and guidance.

CrowdStrike Holdings, Inc. climbed 2.2% to $417.09 in afternoon action Tuesday, part of a rally across cybersecurity names. Shares of Palo Alto Networks edged up 0.4%, while Zscaler picked up around 2.4%.

This shift stands out: the stock’s been behaving closer to a high-growth software name than to a straightforward cyber stock. Lately, that’s hurt. Investors have been wrestling with how a quicker, lower-cost batch of AI might shake up the subscription software space, and the shares have felt it the past couple weeks.

JPMorgan strategists see the recent software selloff as opening up some buying chances, after AI developer Anthropic introduced plug-ins for its Claude Cowork agent—news that helped drag the S&P 500 software and services index down by as much as 17% across six sessions ending Thursday. “The market is pricing in worst-case AI disruption scenarios that are unlikely to materialize over the next three to six months,” wrote Dubravko Lakos-Bujas and his team, who flagged CrowdStrike among their preferred “higher quality and AI-resilient” picks. Over at Morgan Stanley, Katy Huberty called the drop in U.S. software valuations “sentiment-driven, not fundamental,” in a note of her own. Reuters

CrowdStrike flagged ongoing product momentum for investors. On Monday, the company announced it was the sole vendor to earn a Customers’ Choice nod in Gartner Peer Insights’ “Voice of the Customer” report for external attack surface management. “The trust organizations place in CrowdStrike,” said chief technology officer Elia Zaitsev, is behind the recognition—especially as security teams work to spot and patch vulnerabilities at scale. CrowdStrike

External attack surface management, known as EASM, is all about tracking down a company’s internet-facing assets—the ones hackers usually hit up first. That means inventory, but also early alerts. Vendors who’ve managed to integrate this into everyday security routines have found the market quick to back them.

The risk is still right there in the tape. During last week’s tumble, thirty-day implied volatility on the iShares Expanded Tech-Software Sector ETF hovered around 41%—just shy of a 10-month high. Over the last three months, the software and services group trailed the S&P 500 by nearly 24 percentage points. Short interest in the ETF, meanwhile, sat close to record territory, Ortex data show.

CrowdStrike is gearing up for its next big test, with fiscal fourth-quarter and full-year numbers set to drop after the U.S. market shuts on March 3. Management will jump on a conference call at 5:00 p.m. Eastern that same evening.

The March 3 update pulls the conversation out of baskets and positioning, straight into numbers and guidance. Management needs to steer talk toward security demand, sidestepping any new AI-disruption worries. That’s what gives this rebound its potential legs.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors. Follow Khadija Saeed on Google News.

Stock Market Today

  • Abbott jumps 11% as health stocks climb; insurers diverge on earnings
    July 16, 2026, 3:15 PM EDT. Abbott Laboratories (ABT) shares surged 10.9% following a slight earnings beat and a higher 2026 EPS forecast, advancing healthcare stocks. Abbott reported adjusted EPS of $1.31, topping the $1.28 consensus, as medical-device revenue rose 9%. In contrast, UnitedHealth Group (UNH) delivered a robust 30% EPS beat, but shares only advanced 2.6% amid membership declines and a more favorable medical-cost ratio. The Health Care Select Sector SPDR Fund (XLV) climbed 2.2%, beating the market overall. Insurer results were mixed as investors weighed risks tied to disappearing pandemic subsidies and ongoing healthcare demand. Despite raising its profit outlook, Elevance Health shares declined. Abbott's CEO downplayed worries of slower procedure volumes, echoing stable demand seen at Johnson & Johnson.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff
Previous Story

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

Dauch (DCH) stock rises in early trade as board changes and exec share award hit filings
Next Story

Dauch (DCH) stock rises in early trade as board changes and exec share award hit filings

Go toTop